Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer.
Dull PM, Achilles SL, Ahmed R, Barnabas RV, Campos NG, Chirgwin K, Cohen JA, de Sanjosé S, Doorbar J, Einstein MH, Emerson CI, Gottlieb SL, Hildesheim A, Qiao Y, Ruff P, Sampson JN, Sasieni P, Schiffman M, Shin H, Stanley MA, Trimble CL, Wentzensen N, Riemer AB, Schiller JT, Kreimer AR.
Dull PM, et al. Among authors: sampson jn.
Vaccine. 2024 Nov 14;42(25):126100. doi: 10.1016/j.vaccine.2024.07.001. Epub 2024 Jul 14.
Vaccine. 2024.
PMID: 39004526
Free PMC article.